Advisor to Asian Medical and Life Sciences Devices Distribution Group

Our team advised the shareholders of a Asian distributor (the “Company”) of biomedical, life sciences, healthcare, drug discovery, pharmaceutical, laboratories, and industrial test kits, in a sale of a controlling stake to a Japanese multinational corporation, which is portfolio of a global private equity. The buyer develops, manufactures, sells and services medical equipment and solutions across diabetes management, diagnostics, life sciences and healthcare services, which are available in more than 125 countries.

The Company markets and distributes life sciences products and provides its services throughout Southeast Asia and India. With an extensive distribution network in the region, supported by strong expertise and service capabilities in the life sciences field, the Company is a major player in the Southeast Asian market.

This transaction is part of the buyer’s growth strategy, by strengthening existing businesses and identifying ways to add complementary products and services to the group. It follows two completed acquisitions in the same year, which have strengthened their diagnostics and healthcare services businesses respectively. As one of the key pillars of its future growth strategy, the buyer continues to focus on driving expansion in countries in the emerging markets. The acquisition of the Company allows the buyer to take advantage of the Company’s established customer base and services in the region. This will provide additional market opportunities and increase penetration into countries such as India, which can further strengthen the life sciences business.

Our team served as the M&A advisor to the seller and assisted in initiating, structuring, and negotiating the transaction, achieving a good outcome for the seller and the company. This deal exemplifies our track record and deep understanding of the sector and the buyer universe.

Note: This transaction was executed by the Mergerstone leadership team before the incorporation of the company.